580237909	580237909	CD	B-NP	O
|	|	CC	O	O
HLH	HLH	JJ	B-NP	O
|	|	NN	I-NP	O
55508112	55508112	CD	I-NP	O
|	|	:	O	O
|	|	NN	B-NP	O
225363	225363	CD	B-NP	O
|	|	CC	I-NP	O
10/28/2002	10/28/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/10/2002	11/10/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/27/2002	9/27/2002	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
52-year-old	52-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
estimated	estimate	VBD	B-VP	O
EF	EF	NN	B-NP	O
15-20	15-20	CD	B-NP	O
%	%	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
8-10	8-10	CD	I-NP	O
pound	pound	NN	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
3-5	3-5	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
fatigue	fatigue	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
progressed	progress	VBN	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
few	few	JJ	I-NP	O
months	month	NNS	I-NP	O
and	and	CC	I-NP	O
notes	note	NNS	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
now	now	RB	B-ADVP	O
gets	get	VBZ	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
after	after	IN	B-PP	O
walking	walk	VBG	B-VP	O
as	as	RB	B-ADJP	O
few	few	JJ	I-ADJP	O
as	as	IN	B-PP	O
10-20	10-20	CD	B-NP	O
steps	step	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
complains	complain	VBZ	B-VP	O
of	of	IN	B-PP	O
lightheadedness	lightheadedness	NN	B-NP	O
but	but	CC	O	O
denies	deny	VBZ	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
complains	complain	VBZ	B-VP	O
of	of	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
sweats	sweat	NNS	I-NP	O
and	and	CC	I-NP	O
chills	chill	NNS	I-NP	O
without	without	IN	B-PP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
melena	melena	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
lately	lately	RB	B-NP	O
his	his	PRP$	I-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
usual	usual	JJ	B-ADJP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
40s-80s	40s-80	NNS	I-NP	B-DNA
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
dietary	dietary	JJ	I-NP	O
indiscretions	indiscretion	NNS	I-NP	O
or	or	CC	O	O
medical	medical	JJ	B-NP	O
noncompliance	noncompliance	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
discontinuing	discontinue	VBG	B-VP	O
certain	certain	JJ	B-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
medications	medication	NNS	B-NP	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
actually	actually	RB	I-VP	O
be	be	VB	I-VP	O
taking	take	VBG	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
1979	1979	CD	B-NP	O
and	and	CC	I-NP	O
1985	1985	CD	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
three-vessel	three-vessel	JJ	I-NP	O
CABG	CABG	NN	I-NP	O
in	in	IN	B-PP	O
1987	1987	CD	B-NP	O
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
estimated	estimate	VBD	B-VP	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
15-20	15-20	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
cirrhosis	cirrhosis	NN	I-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
nephrolithiasis	nephrolithiasis	NN	B-NP	O
,	,	,	O	O
gallstones	gallstone	NNS	B-NP	O
,	,	,	O	O
irritable	irritable	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
psoriasis	psoriasis	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	known	JJ	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Torsemide	Torsemide	NN	B-NP	O
,	,	,	O	O
Synthroid	Synthroid	JJ	B-NP	O
100	100	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
;	;	:	O	O
Lantus	Lantus	NNP	B-NP	O
98	98	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.	q.	NN	I-NP	O
a.m.	a.m.	NN	I-NP	O
;	;	:	O	O
potassium	potassium	NN	B-NP	O
60	60	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
Humalog	Humalog	NN	B-NP	O
insulin	insulin	NN	I-NP	O
12	12	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.	q.	NN	I-NP	O
a.m.	a.m.	NN	I-NP	O
and	and	CC	O	O
q.	q.	NN	B-NP	O
p.m.	p.m.	NN	I-NP	O
;	;	:	O	O
Restoril	Restoril	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
;	;	:	O	O
Xanax	Xanax	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
;	;	:	O	O
Prozac	Prozac	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
a.m.	a.m.	NN	I-NP	O
;	;	:	O	O
Lipitor	Lipitor	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
;	;	:	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
;	;	:	O	O
Captopril	Captopril	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
Aldactone	Aldactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	FW	I-NP	O
Per	Per	NNP	I-NP	O
patient	patient	NN	I-NP	O
his	his	PRP$	B-NP	O
digoxin	digoxin	NN	I-NP	O
,	,	,	O	O
Captopril	Captopril	NNP	B-NP	O
and	and	CC	I-NP	O
Aldactone	Aldactone	NNP	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
hold	hold	NN	B-NP	O
.	.	.	O	O

Apparently	Apparently	RB	B-ADVP	O
these	these	DT	B-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
clinic	clinic	JJ	I-NP	O
visit	visit	NN	I-NP	O
on	on	IN	B-PP	O
1/23/02	1/23/02	CD	B-NP	O
via	via	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Mcmeans	Mcmeans	NNP	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
orthostatic	orthostatic	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
torsemide	torsemide	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
five	five	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
96.8	96.8	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
72	72	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
91/63	91/63	CD	I-NP	O
,	,	,	O	O
breathing	breathe	VBG	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
comfortable	comfortable	JJ	I-NP	O
,	,	,	I-NP	O
pleasant	pleasant	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
and	and	CC	O	O
oriented	orient	VBD	B-VP	O
x	x	NN	B-NP	B-DNA
3	3	CD	I-NP	I-DNA
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Normocephalic	Normocephalic	JJ	B-NP	O
,	,	,	I-NP	O
atraumatic	atraumatic	JJ	I-NP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
equal	equal	JJ	I-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
and	and	CC	I-NP	O
accommodation	accommodation	NN	I-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Moist	Moist	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
estimated	estimate	VBN	B-VP	O
at	at	IN	B-PP	O
12	12	CD	B-NP	O
cm/water	cm/water	NN	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Decreased	Decrease	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
at	at	IN	B-PP	O
bases	base	NNS	B-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADJP	O
clear	clear	JJ	I-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Normal	Normal	JJ	B-NP	O
S1S2	S1S2	NN	I-NP	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
appreciated	appreciate	VBN	B-VP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	NNP	B-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Warm	Warm	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
or	or	CC	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
+	+	SYM	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Creatinine	Creatinine	NN	B-NP	B-protein
1.2	1.2	CD	I-NP	I-protein
,	,	,	O	O
troponin-I	troponin-I	NN	B-NP	O
0.06	0.06	CD	I-NP	O
.	.	.	O	O

Electrocardiogram	Electrocardiogram	NN	B-NP	O
showing	show	VBG	B-VP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
67	67	CD	B-NP	O
beats/minute	beats/minute	NN	I-NP	O
,	,	,	O	O
first	first	JJ	B-NP	O
degree	degree	NN	I-NP	O
AV	AV	NN	I-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
axis	axis	NN	B-NP	O
deviation	deviation	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

Q	Q	NN	B-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
and	and	CC	O	O
AVF	AVF	NN	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
old	old	JJ	B-NP	O
inferior	inferior	JJ	I-NP	O
infarct	infarct	NN	I-NP	O
.	.	.	O	O

All	All	PDT	B-NP	O
these	these	DT	I-NP	O
findings	finding	NNS	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
prior	prior	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
in	in	IN	B-PP	O
2/14	2/14	CD	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

ISCHEMIC	ISCHEMIC	NN	B-NP	O
CARDIOMYOPATHY	CARDIOMYOPATHY	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

VOLUME	VOLUME	NNP	B-NP	O
OVERLOAD	OVERLOAD	NNP	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

DIABETES	DIABETES	NNS	B-NP	O
MELLITUS	MELLITUS	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

HYPOTHYROIDISM	HYPOTHYROIDISM	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Cardiovascular	Cardiovascular	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
clinically	clinically	RB	B-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBD	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
IV	IV	CD	B-NP	O
boluses	bolus	NNS	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresing	diurese	VBG	I-VP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
on	on	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
IV	IV	CD	I-NP	O
or	or	CC	O	O
p.o.	p.o.	FW	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
spironolactone	spironolactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	FW	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
clinical	clinical	JJ	I-NP	O
volume	volume	NN	I-NP	O
status	status	NN	I-NP	O
were	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
and	and	CC	O	O
accordingly	accordingly	RB	B-ADVP	O
on	on	IN	B-PP	O
8/12/02	8/12/02	CD	B-NP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	O	O
tailored	tailor	VBN	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
report	report	NN	B-NP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
on	on	IN	B-PP	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
was	be	VBD	B-VP	O
17	17	CD	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
wedge	wedge	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
43	43	CD	B-NP	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
65/37	65/37	CD	B-NP	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
still	still	RB	B-ADVP	O
has	have	VBZ	B-VP	O
substantial	substantial	JJ	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
therapy	therapy	NN	B-NP	O
his	his	PRP$	B-NP	O
vasodilators	vasodilator	NNS	I-NP	O
were	be	VBD	B-VP	O
cautiously	cautiously	RB	I-VP	O
added	add	VBN	I-VP	O
to	to	TO	I-VP	O
decrease	decrease	VB	I-VP	O
his	his	PRP$	B-NP	O
systemic	systemic	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
and	and	CC	O	O
total	total	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
with	with	IN	B-PP	O
success	success	NN	B-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Captopril	Captopril	NNP	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
PA	PA	NN	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
6/24/02	6/24/02	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
10	10	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
,	,	,	O	O
spironolactone	spironolactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	FW	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
at	at	IN	B-PP	O
or	or	CC	I-PP	O
near	near	IN	I-PP	O
euvolemia	euvolemia	NN	B-NP	O
on	on	IN	B-PP	O
11/10/02	11/10/02	CD	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
diuretic	diuretic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
and	and	CC	O	O
spironolactone	spironolactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	RB	B-ADVP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
Captopril	Captopril	NNP	B-NP	O
6.25	6.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
Electrocardiogram	Electrocardiogram	NN	B-NP	O
with	with	IN	B-PP	O
first	first	JJ	B-NP	O
degree	degree	NN	I-NP	O
AV	AV	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
significant	significant	JJ	B-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
further	further	JJ	I-NP	O
workup	workup	NN	I-NP	O
was	be	VBD	B-VP	O
pursued	pursue	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
rhythm	rhythm	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Endocrine	Endocrine	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
how	how	WRB	B-ADVP	O
this	this	DT	B-NP	O
came	come	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
but	but	CC	O	O
at	at	IN	B-PP	O
some	some	DT	B-NP	O
point	point	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
his	his	PRP$	B-NP	O
Synthroid	Synthroid	NNP	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
stopped	stop	VBN	I-VP	O
and	and	CC	O	O
only	only	RB	B-ADVP	O
relatively	relatively	RB	I-ADVP	O
recently	recently	RB	B-ADVP	O
restarted	restart	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
maintained	maintain	VBN	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
225	225	CD	B-NP	O
mcg	mcg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Synthroid	Synthroid	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
endocrinologist	endocrinologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Escudero	Escudero	NNP	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Synthroid	Synthroid	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
relatively	relatively	RB	I-NP	O
low	low	JJ	I-NP	O
dose	dose	NN	I-NP	O
and	and	CC	O	O
titrated	titrate	VBN	B-VP	O
slowly	slowly	RB	B-ADVP	O
upwards	upwards	RB	I-ADVP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
his	his	PRP$	B-NP	O
severe	severe	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
concern	concern	NN	B-NP	O
that	that	IN	B-SBAR	O
increasing	increase	VBG	B-VP	O
his	his	PRP$	B-NP	O
dose	dose	NN	I-NP	O
too	too	RB	B-ADVP	O
quickly	quickly	RB	I-ADVP	O
would	would	MD	B-VP	O
precipitate	precipitate	VB	I-VP	O
angina	angina	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
his	his	PRP$	B-NP	O
TSH	TSH	NN	I-NP	O
was	be	VBD	B-VP	O
50	50	CD	B-NP	O
and	and	CC	B-PP	O
after	after	IN	B-PP	O
some	some	DT	B-NP	O
discussion	discussion	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Pimpare	Pimpare	NNP	I-NP	O
his	his	PRP$	B-NP	O
Synthroid	Synthroid	NNP	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
125	125	CD	B-NP	O
mcg	mcg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
On	On	IN	B-PP	O
9/22/02	9/22/02	CD	B-NP	O
an	an	DT	B-NP	O
endocrine	endocrine	JJ	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
requested	request	VBN	I-VP	O
because	because	RB	O	O
on	on	IN	B-PP	O
7/30/02	7/30/02	CD	B-NP	O
his	his	PRP$	I-NP	O
repeat	repeat	NN	I-NP	O
TSH	TSH	NN	I-NP	O
of	of	IN	B-PP	O
75.8	75.8	CD	B-NP	O
,	,	,	O	O
T4	T4	CD	B-NP	O
of	of	IN	B-PP	O
6.5	6.5	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
THBR	THBR	NN	I-NP	B-protein
of	of	IN	B-PP	O
1.10	1.10	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-NP	O
consult	consult	NN	I-NP	O
recommended	recommend	VBD	B-VP	O
increasing	increase	VBG	I-VP	O
Synthroid	Synthroid	JJ	B-ADJP	O
to	to	TO	B-PP	O
150	150	CD	B-NP	O
mcg	mcg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
and	and	CC	O	O
slowly	slowly	RB	B-VP	O
titrating	titrate	VBG	I-VP	O
Synthroid	Synthroid	JJ	B-NP	O
upwards	upward	NNS	I-NP	O
by	by	IN	B-PP	O
no	no	DT	B-NP	O
more	more	JJR	I-NP	O
than	than	IN	I-NP	O
25	25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
q.	q.	NN	I-NP	O
3-4	3-4	CD	B-NP	O
weeks	week	NNS	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
200	200	CD	B-NP	O
mcg	mcg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
again	again	RB	B-VP	O
slowly	slowly	RB	I-VP	O
titrating	titrate	VBG	I-VP	O
upwards	upward	NNS	B-NP	O
to	to	TO	B-VP	O
reduce	reduce	VB	I-VP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
precipitating	precipitate	VBG	B-VP	O
angina	angina	NN	B-NP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
done	do	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
basis	basis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
Type	Type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
doses	dose	NNS	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
titrated	titrate	VBN	I-VP	O
downwards	downward	NNS	B-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
diabetes	diabete	VBZ	B-VP	O
mellitus	mellitus	NN	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
low	low	JJ	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
relatively	relatively	RB	I-NP	O
healthy	healthy	JJ	I-NP	O
diet	diet	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
required	require	VBD	B-VP	O
only	only	RB	B-NP	O
60	60	CD	I-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
insulin	insulin	NN	I-NP	O
q.	q.	NN	I-NP	O
a.m.	a.m.	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
that	that	DT	B-NP	O
dose	dose	NN	I-NP	O
with	with	IN	B-PP	O
Humalog	Humalog	NN	B-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.	q.	NN	I-NP	O
a.m.	a.m.	NN	I-NP	O
and	and	CC	O	O
q.	q.	NN	B-NP	O
p.m.	p.m.	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
and	and	CC	O	O
possibly	possibly	RB	B-VP	O
titrated	titrate	VBN	I-VP	O
back	back	RB	B-ADVP	O
upwards	upwards	RB	B-ADVP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
endocrinologist	endocrinologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Wakeham	Wakeham	NNP	I-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Psychiatric	Psychiatric	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
depression	depression	NN	B-NP	O
and	and	CC	B-PP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
medications	medication	NNS	I-NP	O
of	of	IN	B-PP	O
Prozac	Prozac	NNP	B-NP	O
and	and	CC	I-NP	O
Restoril	Restoril	NNP	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Prozac	Prozac	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
upwards	upward	NNS	B-NP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
a.m.	a.m.	FW	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
notable	notable	JJ	I-NP	O
side	side	NN	I-NP	O
effects	effect	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
a.m.	a.m.	RB	B-NP	O
No	No	DT	I-NP	O
further	further	JJ	I-NP	O
psychiatric	psychiatric	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
or	or	CC	I-NP	O
interventions	intervention	NNS	I-NP	O
were	be	VBD	B-VP	O
required	require	VBN	I-VP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
inpatient	inpatient	JJ	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
mood	mood	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Renal	Renal	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
remaining	remain	VBG	B-VP	O
relatively	relatively	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
despite	despite	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
further	further	JJ	I-NP	O
renal	renal	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
or	or	CC	I-NP	O
intervention	intervention	NN	I-NP	O
was	be	VBD	B-VP	O
required	require	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
11/10/02	11/10/02	NN	B-NP	O
on	on	IN	B-PP	O
e	e	NN	B-NP	O
following	follow	VBG	B-PP	O
medications	medication	NNS	B-NP	O
:	:	:	O	O
spironolactone	spironolactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
;	;	:	O	O
Captopril	Captopril	NNP	B-NP	O
6.25	6.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
torsemide	torsemide	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
simvastatin	simvastatin	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
;	;	:	O	O
Lantus	Lantus	NN	B-NP	O
insulin	insulin	NN	I-NP	O
60	60	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.	q.	NN	I-NP	O
a.m.	a.m.	NN	I-NP	O
;	;	:	O	O
Humalog	Humalog	NN	B-NP	O
insulin	insulin	NN	I-NP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.	q.	NN	I-NP	O
a.m.	a.m.	NN	I-NP	O
and	and	CC	O	O
q.	q.	NN	B-NP	O
p.m.	p.m.	NN	I-NP	O
;	;	:	O	O
K-Dur	K-Dur	NNP	B-NP	O
40	40	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
;	;	:	O	O
Synthroid	Synthroid	JJ	B-NP	O
150	150	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
;	;	:	O	O
Prozac	Prozac	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
a.m.	a.m.	NN	I-NP	O
;	;	:	O	O
Restoril	Restoril	NNP	B-NP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	FW	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
,	,	,	O	O
ISCHEMIC	ISCHEMIC	NNP	B-NP	O
CARDIOMYOPATHY	CARDIOMYOPATHY	NNP	I-NP	O
,	,	,	O	O
DIABETES	DIABETES	NNP	B-NP	O
MELLITUS	MELLITUS	NNP	I-NP	O
,	,	,	O	O
HYPOTHYROIDISM	HYPOTHYROIDISM	NN	B-NP	O
,	,	,	O	O
DEPRESSION	DEPRESSION	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
,	,	,	O	O
ISCHEMIC	ISCHEMIC	NNP	B-NP	O
CARDIOMYOPATHY	CARDIOMYOPATHY	NNP	I-NP	O
,	,	,	O	O
VOLUME	VOLUME	NNP	B-NP	O
OVERLOAD	OVERLOAD	NNP	I-NP	O
,	,	,	O	O
HYPOTHYROIDISM	HYPOTHYROIDISM	NNP	B-NP	O
,	,	,	O	O
DIABETES	DIABETES	NNP	B-NP	O
MELLITUS	MELLITUS	NNP	I-NP	O
,	,	,	O	O
DEPRESSION	DEPRESSION	NN	B-NP	O
.	.	.	O	O

CONDITION	CONDITION	NNP	B-NP	O
UPON	UPON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
afebrile	afebrile	NN	I-NP	O
on	on	IN	B-PP	O
11/10/02	11/10/02	CD	B-NP	O
without	without	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
complaints	complaint	NNS	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
arranged	arrange	VBN	B-VP	O
to	to	TO	I-VP	O
visit	visit	VB	I-VP	O
him	him	PRP	B-NP	O
on	on	IN	B-PP	O
8/13/02	8/13/02	CD	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
time	time	NN	I-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
his	his	PRP$	B-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
his	his	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
adjust	adjust	VB	I-VP	O
his	his	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
and	and	CC	I-NP	O
diuretic	diuretic	JJ	I-NP	O
dose	dose	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Edwardson	Edwardson	NNP	I-NP	O
in	in	IN	B-PP	O
1-3	1-3	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
endocrinologist	endocrinologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Adelmund	Adelmund	NNP	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
arranged	arrange	VBN	I-VP	O
for	for	IN	B-PP	O
home	home	NN	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
to	to	TO	B-VP	O
begin	begin	VB	I-VP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
XAVIER	XAVIER	NN	B-NP	O
TOBIAS	TOBIAS	NN	I-NP	O
SCHOENINGER	SCHOENINGER	NN	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
BJ53	BJ53	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MARQUIS	MARQUIS	NNP	B-NP	O
J.	J.	NNP	I-NP	O
BENNET	BENNET	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AD2	AD2	NNP	I-NP	O
PA338/996227	PA338/996227	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
12672	12672	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

AKFM0O92DI	AKFM0O92DI	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
8/13/02	8/13/02	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/13/02	8/13/02	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

HOWARD	HOWARD	NNP	B-NP	O
N.	N.	NNP	I-NP	O
DIGRAZIA	DIGRAZIA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
UY1	UY1	NNP	I-NP	O

